By Lisa Kerner
Erie, Pa., April 5 - Sciona, Inc. said it has closed a $6.5 million private round of financing. Proceeds from the financing will be used to continue the development of Sciona's nutra-genetics business.
Financing participants included DSM Venturing, Prelude Trust, Burrill and Co., BioVentures Inc., BASF Venture Capital, and Semola Ltd.
"Sciona believes that breakthroughs in the collection and analysis of genetic data will allow us to meet the growing demand of a more health conscious population desiring customized, direct access to personalized health information," company founder and chairman Chris Martin said in a news release.
"The proprietary Cellf kit is the leading product supplying non-medical genetic data directly to consumers."
The Cellf testing procedure allows individuals to collect their own DNA samples in the privacy of their home.
Located in Boulder, Colo., Sciona provides personalized health and nutrition recommendations based the diet, lifestyle and unique genetic profile of individuals.
| Issuer: | Sciona, Inc.
|
| Issue: | Private financing
|
| Amount: | $6.5 million
|
| Investors: | DSM Venturing, Prelude Trust, Burrill and Co., BioVentures Inc., BASF Venture Capital, Semola Ltd.
|
| Announcement date: | April 5
|
|
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
